CAD 0.94
(2.17%)
Year | Net Income | Net Income Growth |
---|---|---|
2023 | -533.04 Thousand USD | -219.13% |
2022 | 447.45 Thousand USD | 144.1% |
2021 | -1.01 Million USD | 67.84% |
2020 | -3.15 Million USD | 67.53% |
2019 | -9.71 Million USD | -28.23% |
2018 | -7.57 Million USD | -2405.51% |
2017 | -302.39 Thousand USD | 97.07% |
2016 | -10.33 Million USD | -407.9% |
2015 | -2.03 Million USD | 63.81% |
2014 | -5.62 Million USD | -38.99% |
2013 | -4.04 Million USD | -43.05% |
2012 | -2.82 Million USD | -267.99% |
2011 | -768.73 Thousand USD | -18.36% |
2010 | -649.48 Thousand USD | -97.49% |
2009 | -328.86 Thousand USD | -591.59% |
2008 | -47.55 Thousand USD | 0.0% |
Year | Net Income | Net Income Growth |
---|---|---|
2024 Q2 | -4.19 Million USD | 0.0% |
2024 Q3 | -7.68 Million USD | -83.09% |
2023 Q3 | 269.65 Thousand USD | -34.68% |
2023 FY | -533.04 Thousand USD | -219.13% |
2023 Q2 | 412.84 Thousand USD | -30.33% |
2023 Q1 | 592.53 Thousand USD | 221.36% |
2023 Q4 | -2.1 Million USD | -880.03% |
2022 Q1 | 155.44 Thousand USD | 186.4% |
2022 Q3 | 322.35 Thousand USD | -68.47% |
2022 Q4 | -488.24 Thousand USD | -251.46% |
2022 Q2 | 1.02 Million USD | 557.82% |
2022 FY | 447.45 Thousand USD | 144.1% |
2021 Q3 | -473.21 Thousand USD | 79.63% |
2021 FY | -1.01 Million USD | 67.84% |
2021 Q4 | -179.9 Thousand USD | 61.98% |
2021 Q1 | -1 Million USD | -1094.23% |
2021 Q2 | -2.32 Million USD | -132.13% |
2020 FY | -3.15 Million USD | 67.53% |
2020 Q4 | -83.79 Thousand USD | 89.46% |
2020 Q2 | -1.2 Million USD | -456.03% |
2020 Q3 | -794.78 Thousand USD | 34.14% |
2020 Q1 | -217.04 Thousand USD | 89.6% |
2019 Q2 | -1.64 Million USD | 65.65% |
2019 Q4 | -2.08 Million USD | -172.61% |
2019 FY | -9.71 Million USD | -28.23% |
2019 Q1 | -4.79 Million USD | -91.02% |
2019 Q3 | -765.73 Thousand USD | 53.55% |
2018 Q3 | -128.81 Thousand CAD | -30.38% |
2018 FY | -7.57 Million USD | -2405.51% |
2018 Q4 | -2.51 Million USD | -1850.22% |
2018 Q2 | -98.79 Thousand USD | -35.12% |
2018 Q1 | -73.11 Thousand USD | 26.24% |
2017 Q3 | -995.25 Thousand USD | -575.39% |
2017 Q2 | -147.36 Thousand USD | -139.34% |
2017 Q1 | -61.56 Thousand USD | 86.62% |
2017 FY | -302.39 Thousand USD | 97.07% |
2017 Q4 | -99.13 Thousand USD | 90.04% |
2016 Q3 | 130.82 Thousand USD | 120.01% |
2016 FY | -10.33 Million USD | -407.9% |
2016 Q2 | -653.82 Thousand USD | 2.66% |
2016 Q4 | -460.16 Thousand USD | -451.74% |
2016 Q1 | -671.69 Thousand CAD | 92.7% |
2015 Q1 | 205.15 Thousand USD | 134.73% |
2015 Q4 | -9.2 Million USD | -404.37% |
2015 Q3 | 3.02 Million USD | 164.05% |
2015 Q2 | -4.72 Million USD | -2401.2% |
2015 FY | -2.03 Million USD | 63.81% |
2014 Q1 | -360.93 Thousand USD | -241.66% |
2014 FY | -5.62 Million USD | -38.99% |
2014 Q2 | -4.41 Million USD | -1122.97% |
2014 Q3 | -736.71 Thousand USD | 83.31% |
2014 Q4 | -590.69 Thousand USD | 19.82% |
2013 Q1 | -365.98 Thousand USD | -67.59% |
2013 FY | -4.04 Million USD | -43.05% |
2013 Q4 | -105.64 Thousand USD | 96.86% |
2013 Q3 | -3.35 Million USD | -2871.8% |
2013 Q2 | -113.05 Thousand USD | 69.11% |
2012 Q3 | -996.95 Thousand USD | -20.08% |
2012 FY | -2.82 Million USD | -267.99% |
2012 Q2 | -830.21 Thousand USD | 45.26% |
2012 Q1 | -1.51 Million USD | -429.23% |
2012 Q4 | -218.38 Thousand USD | 78.09% |
2011 Q3 | -300.72 Thousand USD | -21.48% |
2011 Q4 | 460.66 Thousand USD | 253.18% |
2011 Q1 | -118.98 Thousand USD | -22.55% |
2011 FY | -768.73 Thousand USD | -18.36% |
2011 Q2 | -247.54 Thousand USD | -108.04% |
2010 Q3 | -467.33 Thousand USD | -556.2% |
2010 Q2 | -71.21 Thousand USD | -103.72% |
2010 Q1 | -34.95 Thousand USD | 53.95% |
2010 FY | -649.48 Thousand USD | -97.49% |
2010 Q4 | -97.09 Thousand USD | 79.22% |
2009 Q4 | -75.91 Thousand USD | 66.69% |
2009 Q1 | -7657.04 USD | -43.67% |
2009 FY | -328.86 Thousand USD | -591.59% |
2009 Q3 | -227.88 Thousand USD | -297.08% |
2009 Q2 | -57.38 Thousand USD | -649.49% |
2008 FY | -47.55 Thousand USD | 0.0% |
2008 Q4 | -5329.74 USD | 0.0% |
Name | Net Income | Net Income Difference |
---|---|---|
Aion Therapeutic Inc. | -6.28 Million CAD | 91.522% |
Ayurcann Holdings Corp. | -3.96 Million CAD | 86.566% |
Blueberries Medical Corp. | -1.63 Million CAD | 67.406% |
The BC Bud Corporation | -1.22 Million CAD | 56.453% |
BioNxt Solutions Inc. | -7.72 Million CAD | 93.098% |
CordovaCann Corp. | -6.88 Million CAD | 92.258% |
Christina Lake Cannabis Corp. | -4.13 Million CAD | 87.099% |
Captor Capital Corp. | -11.38 Million CAD | 95.316% |
City View Green Holdings Inc. | -2.44 Million CAD | 78.231% |
1CM Inc. | -913.85 Thousand CAD | 41.671% |
Global Hemp Group Inc. | -2.58 Million CAD | 79.344% |
Greenway Greenhouse Cannabis Corporation | -4.72 Million CAD | 88.713% |
IM Cannabis Corp. | -9.49 Million CAD | 94.388% |
Lobe Sciences Ltd. | -4.7 Million CAD | 88.676% |
Maple Leaf Green World Inc. | -1.09 Million CAD | 51.166% |
Mountain Valley MD Holdings Inc. | -7.67 Million CAD | 93.05% |
Nextleaf Solutions Ltd. | 223.33 Thousand CAD | 338.674% |
Ovation Science Inc. | -813.14 Thousand CAD | 34.447% |
Pharmadrug Inc. | -13.2 Million CAD | 95.962% |
Captiva Verde Wellness Corp. | -6.08 Million CAD | 91.24% |
RAMM Pharma Corp. | -7.72 Million CAD | 93.096% |
RIV Capital Inc. | -106.76 Million CAD | 99.501% |
Revive Therapeutics Ltd. | -5.61 Million CAD | 90.513% |
Red White & Bloom Brands Inc. | -138.89 Million CAD | 99.616% |
SLANG Worldwide Inc. | -19.36 Million CAD | 97.248% |
1933 Industries Inc. | -13.36 Million CAD | 96.011% |
Red Light Holland Corp. | -7.62 Million CAD | 93.011% |
Top Strike Resources Corp. | -1.72 Million CAD | 69.01% |
Xebra Brands Ltd. | -1.95 Million CAD | 72.768% |
Adastra Holdings Ltd. | -3.54 Million CAD | 84.962% |